Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Klaus Toyka

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Disorders

Chemicals & Drugs

Physiology

Lymphocyte Activation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
87
Hartung, Hans-Peter
82
Gold, Ralf
39
Zielasek, Jürgen
35
Jung, Stefan
22
Reiners, Karlheinz
21
Rieckmann, Peter
20
Weishaupt, Andreas
18
Naumann, Markus
16
Martini, Rudolf
16
Mäurer, Mathias
15
Sommer, Claudia
14
Archelos, Juan
13
Flachenecker, Peter
13
Schneider, Christiane
12
Magnus, Tim

Sign-in to see all Coauthors

Publications

TOP 3
Geis C; Beck M; Jablonka S; Weishaupt A; Toyka K V; Sendtner M; Sommer C
Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons.
Bayas A; Stasiolek M; Kruse N; Toyka K V; Selmaj K; Gold R
Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.
Huang Yu-Hwa; Zozulya Alla L; Weidenfeller Christian; Metz Imke; Buck Dorothea; Toyka Klaus V; Brück Wolfgang; Wiendl Heinz
Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Klaus Toyka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Geis C; Beck M; Jablonka S; Weishaupt A; Toyka K V; Sendtner M; Sommer C
Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons.
Neurobiology of disease 2009;36(1):191-9.
2009: Bayas A; Stasiolek M; Kruse N; Toyka K V; Selmaj K; Gold R
Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.
Clinical and experimental immunology 2009;157(3):332-42.
2009: Huang Yu-Hwa; Zozulya Alla L; Weidenfeller Christian; Metz Imke; Buck Dorothea; Toyka Klaus V; Brück Wolfgang; Wiendl Heinz
Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Annals of neurology 2009;66(2):171-83.
2008: Schäfers Maria; Neukirchen Sebastian; Toyka Klaus V; Sommer Claudia
Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy.
Journal of the peripheral nervous system : JPNS 2008;13(1):81-91.
2008: Vlcková-Moravcová Eva; Bednarík Josef; Dusek Ladislav; Toyka Klaus V; Sommer Claudia
Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies.
Muscle & nerve 2008;37(1):50-60.
2008: Stenner Max-Philipp; Waschbisch Anne; Buck Dorothea; Doerck Sebastian; Einsele Hermann; Toyka Klaus V; Wiendl Heinz
Effects of natalizumab treatment on Foxp3+ T regulatory cells.
PloS one 2008;3(10):e3319.
2007: Tersar Kristian; Boentert Matthias; Berger Philipp; Bonneick Sonja; Wessig Carsten; Toyka Klaus V; Young Peter; Suter Ueli
Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2.
Human molecular genetics 2007;16(24):2991-3001.
2007: Chan Andrew; Lee De-Hyung; Linker Ralf; Mohr Alexander; Toyka Klaus V; Gold Ralf
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease.
Journal of neurology 2007;254(11):1604-6.
2007: Hofstetter Harald H; Grau Catharina; Buttmann Mathias; Forsthuber Thomas G; Gaupp Stefanie; Toyka Klaus V; Gold Ralf
The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells.
Cytokine 2007;40(1):35-43.
2007: Buchwald Brigitte; Zhang Gang; Vogt-Eisele Angela K; Zhang Weiyi; Ahangari Raheleh; Griffin John W; Hatt Hanns; Toyka Klaus V; Sheikh Kazim A
Anti-ganglioside antibodies alter presynaptic release and calcium influx.
Neurobiology of disease 2007;28(1):113-21.
2007: Kosinski Christoph M; Schlangen Christiane; Gellerich Frank N; Gizatullina Zemfira; Deschauer Markus; Schiefer Johannes; Young Anne B; Landwehrmeyer Georg Bernhard; Toyka Klaus V; Sellhaus Bernd; Lindenberg Katrin S
Myopathy as a first symptom of Huntington's disease in a Marathon runner.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1637-40.
2007: Uçeyler Nurcan; Rogausch Jan P; Toyka Klaus V; Sommer Claudia
Differential expression of cytokines in painful and painless neuropathies.
Neurology 2007;69(1):42-9.
2007: Beck Marcus; Sendtner Michael; Toyka Klaus V
Novel SOD1 N86K mutation is associated with a severe phenotype in familial ALS.
Muscle & nerve 2007;36(1):111-4.
2007: Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink H K; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
The Journal of pathology 2007;211(5):563-71.
2007: Hofstetter Harald H; Toyka Klaus V; Tary-Lehmann Magdalena; Lehmann Paul V
Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(3):1372-8.
2007: Siglienti Ines; Chan Andrew; Kleinschnitz Christoph; Jander Sebastian; Toyka Klaus V; Gold Ralf; Stoll Guido
Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions.
Journal of neuropathology and experimental neurology 2007;66(1):47-56.
2006: Toyka Klaus V
Ptosis in myasthenia gravis: extended fatigue and recovery bedside test.
Neurology 2006;67(8):1524.
2006: Tischner Denise; Weishaupt Andreas; van den Brandt Jens; Müller Nora; Beyersdorf Niklas; Ip Chi Wang; Toyka Klaus V; Hünig Thomas; Gold Ralf; Kerkau Thomas; Reichardt Holger M
Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
Brain : a journal of neurology 2006;129(Pt 10):2635-47.
2006: Schneider-Gold Christiane; Wessig Carsten; Höpker Martin; Erdlenbruch Bernhard; Gold Ralf; Toyka Klaus
Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome.
Journal of neurology 2006;253(9):1236-7.
2006: Hofstetter Harald H; Lühder Fred; Toyka Klaus V; Gold Ralf
IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors.
Cytokine 2006;34(3-4):184-97.
2006: Stasiolek Mariusz; Bayas Antonios; Kruse Niels; Wieczarkowiecz Anja; Toyka Klaus V; Gold Ralf; Selmaj Krzysztof
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.
Brain : a journal of neurology 2006;129(Pt 5):1293-305.
2006: Wrabetz Lawrence; D'Antonio Maurizio; Pennuto Maria; Dati Gabriele; Tinelli Elisa; Fratta Pietro; Previtali Stefano; Imperiale Daniele; Zielasek Jurgen; Toyka Klaus; Avila Robin L; Kirschner Daniel A; Messing Albee; Feltri M Laura; Quattrini Angelo
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(8):2358-68.
2006: Hofstetter Harald H; Toyka Klaus V; Gold Ralf
Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
Neuroscience letters 2006;391(3):127-30.
2005: Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka K V
Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Neurology 2005;65(12):1924-9.
2005: Bonneick Sonja; Boentert Matthias; Berger Philipp; Atanasoski Suzana; Mantei Ned; Wessig Carsten; Toyka Klaus V; Young Peter; Suter Ueli
An animal model for Charcot-Marie-Tooth disease type 4B1.
Human molecular genetics 2005;14(23):3685-95.
2005: Hofstetter Harald H; Ibrahim Saleh M; Koczan Dirk; Kruse Niels; Weishaupt Andreas; Toyka Klaus V; Gold Ralf
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Cellular immunology 2005;237(2):123-30.
2005: Hofstetter H H; Mössner R; Lesch K P; Linker R A; Toyka K V; Gold R
Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE.
Clinical and experimental immunology 2005;142(1):39-44.
2005: Beyersdorf Niklas; Gaupp Stefanie; Balbach Karen; Schmidt Jens; Toyka Klaus V; Lin Chia-Huey; Hanke Thomas; Hünig Thomas; Kerkau Thomas; Gold Ralf
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
The Journal of experimental medicine 2005;202(3):445-55.
2005: Kroner A; Vogel F; Kolb-Mäurer A; Kruse N; Toyka K V; Hemmer B; Rieckmann P; Mäurer M
Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis.
Journal of neuroimmunology 2005;165(1-2):161-5.
2005: Reinhardt M; Hauff P; Linker R A; Briel A; Gold R; Rieckmann P; Becker G; Toyka K V; Mäurer M; Schirner M
Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ).
NeuroImage 2005;27(2):267-78.
2005: Kroner Antje; Mehling Matthias; Hemmer Bernhard; Rieckmann Peter; Toyka Klaus V; Mäurer Mathias; Wiendl Heinz
A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
Annals of neurology 2005;58(1):50-7.
2005: Beck Marcus; Flachenecker Peter; Magnus Tim; Giess Ralf; Reiners Karlheinz; Toyka Klaus V; Naumann Markus
Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2005;6(2):100-3.
2005: Jung Stefan; Zimmer Sabine; Lüneberg Edeltraud; Frosch Matthias; Karch Helge; Korn Thomas; Toyka Klaus V
Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
Neuroscience letters 2005;381(1-2):175-8.
2005: Linker Ralf A; Rott Evelyn; Hofstetter H H; Hanke T; Toyka Klaus V; Gold Ralf
EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses.
Neurobiology of disease 2005;19(1-2):218-28.
2005: Sommer Claudia; Weishaupt Andreas; Brinkhoff Jörg; Biko Lydia; Wessig Carsten; Gold Ralf; Toyka Klaus V
Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin.
Lancet 2005;365(9468):1406-11.
2005: Buchwald Brigitte; Ahangari Raheleh; Weishaupt Andreas; Toyka Klaus V
Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Muscle & nerve 2005;31(4):487-94.
2005: Berghoff Martin; Samsam Mohtashem; Müller Marcus; Kobsar Igor; Toyka Klaus V; Kiefer Reinhard; Mäurer Mathias; Martini Rudolf
Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene.
Molecular and cellular neurosciences 2005;28(1):118-27.
2005: Chan A; Weilbach F X; Toyka K V; Gold R
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients.
Clinical and experimental immunology 2005;139(1):152-8.
2005: Bates David; Toyka Klaus V; Wolinsky Jerry S; Arnold Douglas
Disease management in multiple sclerosis.
European neurology 2005;53(4):203-5.
2004: Schneider-Gold Christiane; Beer Meinrad; Köstler Herbert; Buchner Stefan; Sandstede Jörn; Hahn Dietbert; Toyka Klaus V
Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study.
Muscle & nerve 2004;30(5):636-44.
2004: Korn Thomas; Magnus Tim; Toyka Klaus; Jung Stefan
Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Journal of leukocyte biology 2004;76(5):950-60.
2004: Bendszus Martin; Koltzenburg Martin; Bartsch Andreas J; Goldbrunner Roland; Günthner-Lengsfeld Thomas; Weilbach Franz X; Roosen Klaus; Toyka Klaus V; Solymosi László
Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: a prospective, randomized trial.
Circulation 2004;110(15):2210-5.
2004: Martini Rudolf; Toyka Klaus V
Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients.
Lancet neurology 2004;3(8):457-65.
2004: Kroner A; Mäurer M; Loserth S; Kleinschnitz C; Hemmer B; Rosche B; Toyka K V; Rieckmann P
Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.
Tissue antigens 2004;64(1):70-3.
2004: Mäurer Mathias; Stoll Guido; Toyka Klaus V
Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness.
Neuromuscular disorders : NMD 2004;14(6):380-2.
2004: Flachenecker Peter; Bihler Irene; Weber F; Gottschalk M; Toyka Klaus V; Rieckmann Peter
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(2):165-9.
2004: Ströbel Philipp; Bauer Andrea; Puppe Bernhard; Kraushaar Til; Krein Axel; Toyka Klaus; Gold Ralf; Semik Michael; Kiefer Reinhard; Nix Wilfred; Schalke Berthold; Müller-Hermelink Hans Konrad; Marx Alexander
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1501-9.
2004: Stoll Guido; Wesemeier Carmen; Gold Ralf; Solymosi Laszlo; Toyka Klaus V; Bendszus Martin
In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging.
Journal of neuroimmunology 2004;149(1-2):142-6.
2004: Kahl Kai G; Schmidt Harald H H W; Jung Stefan; Sherman Paula; Toyka Klaus V; Zielasek Jürgen
Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response.
Neuroscience letters 2004;358(1):58-62.
2004: Jung Stefan; Siglienti Ines; Grauer Oliver; Magnus Tim; Scarlato Guglielmo; Toyka Klaus
Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate.
Journal of neuroimmunology 2004;148(1-2):63-73.
2004: Schoser Benedikt G H; Schneider-Gold Christiane; Kress Wolfram; Goebel Hans-Hilmar; Reilich Peter; Koch Manuela C; Pongratz Dieter E; Toyka Klaus V; Lochmüller Hanns; Ricker Kenneth
Muscle pathology in 57 patients with myotonic dystrophy type 2.
Muscle & nerve 2004;29(2):275-81.
2004: Jung Stefan; Gaupp Stefanie; Korn Thomas; Köllner Gabriele; Hartung Hans-Peter; Toyka Klaus V
Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
Journal of neuroscience research 2004;75(4):524-35.
2004: Visan Lucian; Visan Ioana A; Weishaupt Andreas; Hofstetter Harald H; Toyka Klaus V; Hünig Thomas; Gold Ralf
Tolerance induction by intrathymic expression of P0.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1364-70.
2004: Weilbach F X; Chan A; Toyka K V; Gold R
The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.
Clinical and experimental immunology 2004;135(1):49-55.
2003: Kleinschnitz Christoph; Bendszus Martin; Frank Marco; Solymosi Laszlo; Toyka Klaus V; Stoll Guido
In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003;23(11):1356-61.
2003: Flachenecker P; Rufer A; Bihler I; Hippel C; Reiners K; Toyka K V; Kesselring J
Fatigue in MS is related to sympathetic vasomotor dysfunction.
Neurology 2003;61(6):851-3.
2003: Wolinsky Jerry S; Toyka Klaus V; Kappos Ludwig; Grossberg Sidney E
Interferon-beta antibodies: implications for the treatment of MS.
Lancet neurology 2003;2(9):528.
2003: Chan Andrew; Seguin Rosanne; Magnus Tim; Papadimitriou Christina; Toyka Klaus V; Antel Jack P; Gold Ralf
Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta.
Glia 2003;43(3):231-42.
2003: Schmidt Jens; Metselaar Josbert M; Wauben Marca H M; Toyka Klaus V; Storm Gert; Gold Ralf
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.
Brain : a journal of neurology 2003;126(Pt 8):1895-904.
2003: Wessig C; Klein R; Schneider M F; Toyka K V; Naumann M; Sommer C
Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome.
Neurology 2003;61(2):195-8.
2003: Schmidt Jens; Elflein Karin; Stienekemeier Martina; Rodriguez-Palmero Marta; Schneider Christiane; Toyka Klaus V; Gold Ralf; Hünig Thomas
Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies.
Journal of neuroimmunology 2003;140(1-2):143-52.
2003: Toyka Klaus V; Schneider-Gold Christiane
Oculomotor signs in Lambert-Eaton myasthenic syndrome-coincidence with myasthenia gravis.
Annals of neurology 2003;54(1):135-6; author reply 136-7.
2003: Kahl Kai G; Zielasek Jürgen; Uttenthal L Otto; Rodrigo Jose; Toyka Klaus V; Schmidt Harald H H W
Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat.
Journal of neuroscience research 2003;73(2):198-205.
2003: Korn Thomas; Fischer Klaus-Dieter; Girkontaite Irena; Köllner Gabriele; Toyka Klaus; Jung Stefan
Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming.
Journal of neuroimmunology 2003;139(1-2):17-26.
2003: Flachenecker Peter; Schneider Christiane; Cursiefen Simone; Ricker Kenneth; Toyka Klaus V; Reiners Karlheinz
Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).
Neuromuscular disorders : NMD 2003;13(4):289-93.
2003: Toyka Klaus V; Gold Ralf
The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents.
Neurology 2003;60(8 Suppl 3):S2-7.
2003: Samsam Mohtashem; Mi Weiqian; Wessig Carsten; Zielasek Jürgen; Toyka Klaus V; Coleman Michael P; Martini Rudolf
The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):2833-9.
2003: Krampfl K; Mohammadi B; Buchwald B; Jahn K; Dengler R; Toyka K V; Bufler J
IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.
Muscle & nerve 2003;27(4):435-41.
2003: Kobsar I; Berghoff M; Samsam M; Wessig C; Mäurer M; Toyka K V; Martini R
Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.
Brain : a journal of neurology 2003;126(Pt 4):804-13.
2003: Schneider-Gold C; Beck M; Wessig C; George A; Kele H; Reiners K; Toyka K V
Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.
Neurology 2003;60(3):500-2.
2003: Chan Andrew; Papadimitriou Christina; Graf Wolfgang; Toyka Klaus V; Gold Ralf
Effects of polyclonal immunoglobulins and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells.
Journal of neuroimmunology 2003;135(1-2):161-5.
2003: Gold Ralf; Dalakas Marinos C; Toyka Klaus V
Immunotherapy in autoimmune neuromuscular disorders.
Lancet neurology 2003;2(1):22-32.
2003: Bayas A; Kruse N; Moriabadi N F; Weber F; Hummel V; Wohleben G; Gold R; Toyka K V; Rieckmann P
Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells.
Neuroscience letters 2003;335(3):155-8.
2003: Müllges Wolfgang; Franke Dorothea; Reents Wilko; Babin-Ebell Jörg; Toyka Klaus V
Reduced rate of microembolism by optimized aortic cannula position does not influence early postoperative cognitive performance in CABG patients.
Cerebrovascular diseases (Basel, Switzerland) 2003;15(3):192-8.
2002: Mäurer M; Toyka K V; Gold R
Cellular immunity in inflammatory autoimmune neuropathies.
Revue neurologique 2002;158(12 Pt 2):S7-15.
2002: Flachenecker P; Kümpfel T; Kallmann B; Gottschalk M; Grauer O; Rieckmann P; Trenkwalder C; Toyka K V
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(6):523-6.
2002: Buchwald Brigitte; Ahangari Raheleh; Toyka Klaus V
Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction.
Neuroscience letters 2002;334(1):25-8.
2002: Comi Giancarlo; Roveri Luisa; Swan Antony; Willison Hugh; Bojar Martin; Illa Isabel; Karageorgiou Clementine; Nobile-Orazio Eduardo; van den Bergh Peter; Swan Tony; Hughes Richard; Aubry Jaques; Baumann Nicole; Hadden Robert; Lunn Michael; Knapp Martin; Léger Jean-Marc; Bouche Pierre; Mazanec Radim; Meucci Nicoletta; van der Meché Frans; Toyka Klaus;
A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.
Journal of neurology 2002;249(10):1370-7.
2002: Toyka Klaus V; Müller Bettina; Reichmann Heinz
"Atraumatic" Sprotte needle reduces the incidence of post-lumbar puncture headaches.
Neurology 2002;59(7):1120; author reply 1120-1.
2002: Weishaupt Andreas; Kuhlmann Tanja; Schönrock Lisa M; Toyka Klaus V; Brück Wolfgang; Gold Ralf
Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Acta neuropathologica 2002;104(4):385-90.
2002: Magnus Tim; Chan Andrew; Linker Ralf A; Toyka Klaus V; Gold Ralf
Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system.
Journal of neuropathology and experimental neurology 2002;61(9):760-6.
2002: Magnus Tim; Chan Andrew; Savill John; Toyka Klaus V; Gold Ralf
Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications.
Journal of neuroimmunology 2002;130(1-2):1-9.
2002: Müllges Wolfgang; Babin-Ebell Jörg; Reents Wilko; Toyka Klaus V
Cognitive performance after coronary artery bypass grafting: a follow-up study.
Neurology 2002;59(5):741-3.
2002: Sommer Claudia; Lindenlaub Thies; Zillikens Detlef; Toyka Klaus V; Naumann Markus
Selective loss of cholinergic sudomotor fibers causes anhidrosis in Ross syndrome.
Annals of neurology 2002;52(2):247-50.
2002: Flachenecker Peter; Jung Stefan; Rieckmann Peter; Toyka Klaus V
sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study.
Journal of neurology 2002;249(8):1001-3.
2002: Offenhäusser Martin; Herr Alexandra S; Hartkamp Jörg; Wauben Marca; Magnus Tim; Grauer Oliver; Seubert Silvia; Weishaupt Andreas; Toyka Klaus V; Gold Ralf; Troppmair Jakob
Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation.
Journal of neuroimmunology 2002;129(1-2):97-105.
2002: Kahl K G; Kruse N; Toyka K V; Rieckmann P
Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis.
Journal of the neurological sciences 2002;200(1-2):53-5.
2002: Schäfers Maria; Schmidt Christine; Vogel Carola; Toyka Klaus V; Sommer Claudia
Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve.
Acta neuropathologica 2002;104(2):197-205.
2002: Bayas A; Hummel V; Kallmann B A; Karch C; Toyka K V; Rieckmann P
Human cerebral endothelial cells are a potential source for bioactive BDNF.
Cytokine 2002;19(2):55-8.
2002: Beck M; Giess R; Magnus T; Puls I; Reiners K; Toyka K V; Naumann M
Progressive sudomotor dysfunction in amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2002;73(1):68-70.
2002: Buchwald Brigitte; Ahangari Raheleh; Weishaupt Andreas; Toyka Klaus V
Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
Annals of neurology 2002;51(6):673-80.
2002: Linker Ralf A; Mäurer Mathias; Gaupp Stefanie; Martini Rudolf; Holtmann Bettina; Giess Ralf; Rieckmann Peter; Lassmann Hans; Toyka Klaus V; Sendtner Michael; Gold Ralf
CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
Nature medicine 2002;8(6):620-4.
2002: Mäurer Mathias; Toyka Klaus V; Gold Ralf
Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models.
Neuromuscular disorders : NMD 2002;12(4):405-14.
2002: Beer M; Schneider C; Köstler H; Buchner S; Sandstede J; Toyka K V; Hahn D
Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2002;174(5):573-8.
2002: Magnus T; Beck M; Giess R; Puls I; Naumann M; Toyka K V
Disease progression in amyotrophic lateral sclerosis: predictors of survival.
Muscle & nerve 2002;25(5):709-14.
2002: Giess Ralf; Holtmann Bettina; Braga Massimiliano; Grimm Tiemo; Müller-Myhsok Bertram; Toyka Klaus V; Sendtner Michael
Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
American journal of human genetics 2002;70(5):1277-86.
2002: Toyka Klaus V; Zielasek Jürgen; Stoll Guido
Myelin-derived glycolipids and animal models of Guillain-Barré syndrome.
Annals of neurology 2002;51(4):532; author reply 532-3.
2002: Kieseier Bernd C; Tani Marie; Mahad Don; Oka Nobuyuki; Ho Tony; Woodroofe Nicola; Griffin John W; Toyka Klaus V; Ransohoff Richard M; Hartung Hans-Peter
Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.
Brain : a journal of neurology 2002;125(Pt 4):823-34.
2002: Giess Ralf; Mäurer Mathias; Linker Ralf; Gold Ralf; Warmuth-Metz Monika; Toyka Klaus V; Sendtner Michael; Rieckmann Peter
Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.
Archives of neurology 2002;59(3):407-9.
2002: Willison Hugh; Stoll Guido; Toyka Klaus V; Berger Thomas; Hartung Hans-Peter
Autoimmunity and inflammation in the peripheral nervous system.
Trends in neurosciences 2002;25(3):127-9.
2002: Schneider C; Gold R; Schäfers M; Toyka K V
Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome.
Muscle & nerve 2002;25(2):286-8.
2002: Leussink V I; Zettl U K; Jander S; Pepinsky R B; Lobb R R; Stoll G; Toyka K V; Gold R
Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis.
Acta neuropathologica 2002;103(2):131-6.
2002: Weilbach Franz X; Toyka Klaus V
Does Down's syndrome protect against multiple sclerosis?
European neurology 2002;47(1):52-5.
2001: Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka K V; Gold R; Strominger J L
Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13872-7.
2001: Magnus T; Chan A; Grauer O; Toyka K V; Gold R
Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):5004-10.
2001: Flachenecker P; Reiners K; Krauser M; Wolf A; Toyka K V
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(5):327-34.
2001: Sommer C; Lindenlaub T; Teuteberg P; Schäfers M; Hartung T; Toyka K V
Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy.
Brain research 2001;913(1):86-9.
2001: Korn T; Toyka K; Hartung H P; Jung S
Suppression of experimental autoimmune neuritis by leflunomide.
Brain : a journal of neurology 2001;124(Pt 9):1791-802.
2001: Schneider C; Reiners K; Toyka K V
[Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations]
Der Nervenarzt 2001;72(8):618-24.
2001: Flachenecker P; Toyka K V; Reiners K
[Cardiac arrhythmias in Guillain-Barre syndrome. An overview of the diagnosis of a rare but potentially life-threatening complication]
Der Nervenarzt 2001;72(8):610-7.
2001: Grauer O; Offenhäusser M; Schmidt J; Toyka K V; Gold R
[Glucocorticosteroid therapy in optic neuritis and multiple sclerosis. Evidence from clinical studies and practical recommendations]
Der Nervenarzt 2001;72(8):577-89.
2001: Weishaupt A; Schönrock L M; Stienekemeier M; Toyka K V; Gold R
Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ.
Acta neuropathologica 2001;102(1):75-82.
2001: Schmidt J; Stürzebecher S; Toyka K V; Gold R
Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration.
Journal of neuroscience research 2001;65(1):59-67.
2001: Gold R; Buttgereit F; Toyka K V
Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders.
Journal of neuroimmunology 2001;117(1-2):1-8.
2001: Sommer C; Schäfers M; Marziniak M; Toyka K V
Etanercept reduces hyperalgesia in experimental painful neuropathy.
Journal of the peripheral nervous system : JPNS 2001;6(2):67-72.
2001: Mäurer M; Schmid C D; Bootz F; Zielasek J; Toyka K V; Oehen S; Martini R
Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants.
Molecular and cellular neurosciences 2001;17(6):1094-101.
2001: Weishaupt A; Brück W; Hartung T; Toyka K V; Gold R
Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha.
Neuroscience letters 2001;306(1-2):77-80.
2001: Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka K V; Ertl G; Gold R; Hahn D
Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2001;173(5):399-404.
2001: Jung S; Gaupp S; Hartung H P; Toyka K V
Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat. II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN.
Journal of neuroimmunology 2001;116(1):21-8.
2001: Hummel V; Kallmann B A; Wagner S; Füller T; Bayas A; Tonn J C; Benveniste E N; Toyka K V; Rieckmann P
Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules.
Journal of neuropathology and experimental neurology 2001;60(4):320-7.
2001: Moriabadi N F; Niewiesk S; Kruse N; Jung S; Weissbrich B; ter Meulen V; Toyka K V; Rieckmann P
Influenza vaccination in MS: absence of T-cell response against white matter proteins.
Neurology 2001;56(7):938-43.
2001: Wessig C; Buchwald B; Toyka K V; Martini R
Miller Fisher syndrome: immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction.
Acta neuropathologica 2001;101(3):239-44.
2001: Hadden R D; Karch H; Hartung H P; Zielasek J; Weissbrich B; Schubert J; Weishaupt A; Cornblath D R; Swan A V; Hughes R A; Toyka K V;
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
Neurology 2001;56(6):758-65.
2001: Mäurer M; Gold R; Toyka K V; Rieckmann P
[Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations]
Der Nervenarzt 2001;72(2):108-16.
2001: Kieseier B C; Schneider C; Clements J M; Gearing A J; Gold R; Toyka K V; Hartung H P
Expression of specific matrix metalloproteinases in inflammatory myopathies.
Brain : a journal of neurology 2001;124(Pt 2):341-51.
2001: Carenini S; Mäurer M; Werner A; Blazyca H; Toyka K V; Schmid C D; Raivich G; Martini R
The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0.
The Journal of cell biology 2001;152(2):301-8.
2001: Leussink V I; Jung S; Merschdorf U; Toyka K V; Gold R
High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
Archives of neurology 2001;58(1):91-7.
2001: Kruse N; Moriabadi N F; Toyka K V; Rieckmann P
Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells.
Journal of immunological methods 2001;247(1-2):131-9.
2001: Buchwald B; Bufler J; Carpo M; Heidenreich F; Pitz R; Dudel J; Nobile-Orazio E; Toyka K V
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.
Neurology 2001;56(1):67-74.
2001: Schneider C; Gold R; Reiners K; Toyka K V
Mycophenolate mofetil in the therapy of severe myasthenia gravis.
European neurology 2001;46(2):79-82.
2000: Weishaupt A; Jander S; Brück W; Kuhlmann T; Stienekemeier M; Hartung T; Toyka K V; Stoll G; Gold R
Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7157-63.
2000: George A; Marziniak M; Schäfers M; Toyka K V; Sommer C
Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin.
Pain 2000;88(3):267-75.
2000: Kieseier B C; Krivacic K; Jung S; Pischel H; Toyka K V; Ransohoff R M; Hartung H P
Sequential expression of chemokines in experimental autoimmune neuritis.
Journal of neuroimmunology 2000;110(1-2):121-9.
2000: Kress W; Mueller-Myhsok B; Ricker K; Schneider C; Koch M C; Toyka K V; Mueller C R; Grimm T
Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2).
Neuromuscular disorders : NMD 2000;10(7):478-80.
2000: Niehaus A; Shi J; Grzenkowski M; Diers-Fenger M; Archelos J; Hartung H P; Toyka K; Brück W; Trotter J
Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination.
Annals of neurology 2000;48(3):362-71.
2000: Merkies I S; Schmitz P I; Samijn J P; Meché F G; Toyka K V; van Doorn P A
Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies.
Muscle & nerve 2000;23(9):1393-401.
2000: Schneider C; Ziegler A; Ricker K; Grimm T; Kress W; Reimers C D; Meinck H; Reiners K; Toyka K V
Proximal myotonic myopathy: evidence for anticipation in families with linkage to chromosome 3q.
Neurology 2000;55(3):383-8.
2000: Schmidt J; Gold R; Schönrock L; Zettl U K; Hartung H P; Toyka K V
T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy.
Brain : a journal of neurology 2000;123 ( Pt 7)():1431-41.
2000: Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka K V
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;69(1):121-3.
2000: Schneider C; Matsumoto Y; Kohyama K; Toyka K V; Hartung H P; Gold R
Experimental autoimmune myositis in the lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application.
Journal of neuroimmunology 2000;107(1):83-7.
2000: Ochs G; Penn R D; York M; Giess R; Beck M; Tonn J; Haigh J; Malta E; Traub M; Sendtner M; Toyka K V
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2000;1(3):201-6.
2000: Wohlleben G; Ibrahim S M; Schmidt J; Toyka K V; Hartung H P; Gold R
Regulation of Fas and FasL expression on rat Schwann cells.
Glia 2000;30(4):373-81.
2000: Weishaupt A; Gold R; Hartung T; Gaupp S; Wendel A; Brück W; Toyka K V
Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.
Journal of neuropathology and experimental neurology 2000;59(5):368-76.
2000: Zielasek J; Martini R; Suter U; Toyka K V
Neuromyotonia in mice with hereditary myelinopathies.
Muscle & nerve 2000;23(5):696-701.
2000: Kallmann B A; Hummel V; Lindenlaub T; Ruprecht K; Toyka K V; Rieckmann P
Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1.
Brain : a journal of neurology 2000;123 ( Pt 4)():687-97.
2000: Giess R; Beck M; Goetz R; Nitsch R M; Toyka K V; Sendtner M
Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis.
Neurology 2000;54(4):1003-5.
2000: Gold R; Hartung H P; Toyka K V
Animal models for autoimmune demyelinating disorders of the nervous system.
Molecular medicine today 2000;6(2):88-91.
2000: Kruse N; Greif M; Moriabadi N F; Marx L; Toyka K V; Rieckmann P
Variations in cytokine mRNA expression during normal human pregnancy.
Clinical and experimental immunology 2000;119(2):317-22.
2000: Schmid C D; Stienekemeier M; Oehen S; Bootz F; Zielasek J; Gold R; Toyka K V; Schachner M; Martini R
Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(2):729-35.
2000: Cursiefen S; Flachenecker P; Toyka K V; Rieckmann P
Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.
European neurology 2000;43(3):186-7.
1999: Puls I; Beck M; Giess R; Magnus T; Ochs G; Toyka K V
[Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect]
Der Nervenarzt 1999;70(12):1112-5.
1999: Gold R; Oelschläger M; Pepinsky R B; Sommer C; Hartung H P; Toyka K V
Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis.
Acta neuropathologica 1999;98(6):583-9.
1999: Puls I; Hauck K; Demuth K; Horowski A; Schliesser M; Dörfler P; Scheel P; Toyka K V; Reiners K; Schöning M; Becker G
Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia: A transcranial ultrasound study.
Stroke; a journal of cerebral circulation 1999;30(11):2291-5.
1999: Holtmann B; Zielasek J; Toyka K V; Sendtner M
Comparative analysis of motoneuron loss and functional deficits in PMN mice: implications for human motoneuron disease.
Journal of the neurological sciences 1999;169(1-2):140-7.
1999: Buchwald B; de Baets M; Luijckx G J; Toyka K V
Neonatal Guillain-Barré syndrome: blocking antibodies transmitted from mother to child.
Neurology 1999;53(6):1246-53.
1999: Chan A; Gold R; Giegerich G; Herrmann T; Jung S; Toyka K V; Hartung H P
Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat.
Journal of neuroscience research 1999;58(2):214-25.
1999: Zielasek J; Toyka K V
Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
Annals of the New York Academy of Sciences 1999;883():310-20.
1999: Müllges W; Berg D; Jörg Babin-Ebell J; Toyka K V; Elert O
Cerebral microembolus generation in different extracorporeal circulation systems.
Cerebrovascular diseases (Basel, Switzerland) 1999;9(5):265-9.
1999: Beck M; Giess R; Würffel W; Magnus T; Ochs G; Toyka K V
Comparison of maximal voluntary isometric contraction and Drachman's hand-held dynamometry in evaluating patients with amyotrophic lateral sclerosis.
Muscle & nerve 1999;22(9):1265-70.
1999: Cursiefen S; Flachenecker P; Rieckmann P; Toyka K V
[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients]
Der Nervenarzt 1999;70(8):723-31.
1999: Naumann M; Jost W H; Toyka K V
Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system.
Archives of neurology 1999;56(8):914-6.
1999: Sommer C; Petrausch S; Lindenlaub T; Toyka K V
Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy.
Neuroscience letters 1999;270(1):25-8.
1999: Müllges W; Berg D; Toyka K V
Bilateral cerebral emboli monitoring during extracorporeal circulation.
Ultrasound in medicine & biology 1999;25(5):755-8.
1999: Flachenecker P; Janka M; Goldbrunner R; Toyka K V
Clinical outcome of sural nerve biopsy: a retrospective study.
Journal of neurology 1999;246(2):93-6.
1999: Schneider C; Dalakas M C; Toyka K V; Said G; Hartung H P; Gold R
T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection.
Archives of neurology 1999;56(1):79-83.
1999: Ricker K; Grimm T; Koch M C; Schneider C; Kress W; Reimers C D; Schulte-Mattler W; Mueller-Myhsok B; Toyka K V; Mueller C R
Linkage of proximal myotonic myopathy to chromosome 3q.
Neurology 1999;52(1):170-1.
1999: Rieckmann P; Toyka K V
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]
European neurology 1999;42(3):121-7.
1998: Naumann M; Hofmann E; Toyka K V
Multifocal brain MRI hypointensities secondary to embolic metal fragments from a mechanical heart valve prosthesis: a possible source of epileptic seizures.
Neurology 1998;51(6):1766-7.
1998: Naumann M; Toyka K V; Mansouri Taleghani B; Ahmadpour J; Reiners K; Bigalke H
Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin.
Journal of neurology, neurosurgery, and psychiatry 1998;65(6):924-7.
1998: Buchwald B; Toyka K V; Zielasek J; Weishaupt A; Schweiger S; Dudel J
Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
Annals of neurology 1998;44(6):913-22.
1998: Hadden R D; Cornblath D R; Hughes R A; Zielasek J; Hartung H P; Toyka K V; Swan A V
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Annals of neurology 1998;44(5):780-8.
1998: Martini R; Zielasek J; Toyka K V
Inherited demyelinating neuropathies: from gene to disease.
Current opinion in neurology 1998;11(5):545-56.
1998: Bergmann I; Reiter R; Toyka K V; Koltzenburg M
Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75.
Neuroscience letters 1998;255(2):87-90.
1998: Ochs G; Loew M; Tonn J; Toyka K
Distribution, tolerability and tissue compatibility of intrathecal tizanidine in the sheep.
Acta anaesthesiologica Scandinavica 1998;42(7):786-93.
1998: Enders U; Lobb R; Pepinsky R B; Hartung H P; Toyka K V; Gold R
The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat.
Brain : a journal of neurology 1998;121 ( Pt 7)():1257-66.
1998: Chan A; Gold R; Arp S; Pflughaupt K W; Toyka K V; Reichmann H
[Standardized bicycle ergometry test in mitochondrial myopathies. Indications, interferences and clinical parameters]
Der Nervenarzt 1998;69(6):472-84.
1998: Buchwald B; Dudel J; Toyka K V
Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.
Annals of the New York Academy of Sciences 1998;841():659-69.
1998: Kiefer R; Schweitzer T; Jung S; Toyka K V; Hartung H P
Sequential expression of transforming growth factor-beta1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation.
Journal of neuropathology and experimental neurology 1998;57(5):385-95.
1998: Flachenecker P; Taleghani B M; Gold R; Grossmann R; Wiebecke D; Toyka K V
Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide.
Transfusion science 1998;19 Suppl():43-6.
1998: Kiefer R; Kieseier B C; Brück W; Hartung H P; Toyka K V
Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies.
Brain : a journal of neurology 1998;121 ( Pt 3)():469-79.
1998: Naumann M; Hofmann U; Bergmann I; Hamm H; Toyka K V; Reiners K
Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin.
Archives of dermatology 1998;134(3):301-4.
1998: Knieling J; Weiss H; Faller H; Lang H; Schalke B; Toyka K
[Follow-up of myasthenia gravis. Results of a longitudinal study of the significance of psychosocial predictors]
Der Nervenarzt 1998;69(2):137-44.
1998: Giess R; Goetz R; Schrank B; Ochs G; Sendtner M; Toyka K
Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease.
Muscle & nerve 1998;21(2):236-8.
1998: Buchwald B; Weishaupt A; Toyka K V; Dudel J
Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals.
The European journal of neuroscience 1998;10(1):281-90.
1998: Archelos J J; Trotter J; Previtali S; Weissbrich B; Toyka K V; Hartung H P
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
Annals of neurology 1998;43(1):15-24.
1997: Kruse N; Pette M; Toyka K; Rieckmann P
Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood.
Journal of immunological methods 1997;210(2):195-203.
1997: Jung S; Donhauser T; Toyka K V; Hartung H P
Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Journal of autoimmunity 1997;10(6):519-29.
1997: Toyka K V; Zielasek J; Ricker K; Adlkofer K; Suter U
Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):812-3.
1997: Naumann M; Zellner M; Toyka K V; Reiners K
Treatment of gustatory sweating with botulinum toxin.
Annals of neurology 1997;42(6):973-5.
1997: Sommer C; Schmidt C; George A; Toyka K V
A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy.
Neuroscience letters 1997;237(1):45-8.
1997: Gaupp S; Hartung H P; Toyka K; Jung S
Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.
Journal of neuroimmunology 1997;79(2):129-37.
1997: Weilbach F X; Jung S; Hartung H P; Toyka K V; Giegerich G
T-cell receptor V beta-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis.
Journal of neuroimmunology 1997;79(1):69-75.
1997: Schrank B; Götz R; Gunnersen J M; Ure J M; Toyka K V; Smith A G; Sendtner M
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(18):9920-5.
1997: Lindner A; Schalke B; Toyka K V
Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients.
Journal of neurology 1997;244(8):515-20.
1997: Enders U; Toyka K V; Hartung H P; Gold R
Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
Journal of neuroimmunology 1997;76(1-2):112-6.
1997: Adlkofer K; Frei R; Neuberg D H; Zielasek J; Toyka K V; Suter U
Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(12):4662-71.
1997: Anzini P; Neuberg D H; Schachner M; Nelles E; Willecke K; Zielasek J; Toyka K V; Suter U; Martini R
Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(12):4545-51.
1997: Reichmann H; Goebel H H; Schneider C; Toyka K V
Familial mixed congenital myopathy with rigid spine phenotype.
Muscle & nerve 1997;20(4):411-7.
1997: Weishaupt A; Gold R; Gaupp S; Giegerich G; Hartung H P; Toyka K V
Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1338-43.
1997: Bergmann I; Priestley J V; McMahon S B; Bröcker E B; Toyka K V; Koltzenburg M
Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75.
The European journal of neuroscience 1997;9(1):18-28.
1997: Becker G; Naumann M; Scheubeck M; Hofmann E; Deimling M; Lindner A; Gahn G; Reiners C; Toyka K V; Reiners K
Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis.
Movement disorders : official journal of the Movement Disorder Society 1997;12(1):79-88.
1996: Schneider C; Gold R; Dalakas M C; Schmied M; Lassmann H; Toyka K V; Hartung H P
MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
Journal of neuropathology and experimental neurology 1996;55(12):1205-9.
1996: Naumann M; Becker G; Toyka K V; Supprian T; Reiners K
Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography.
Neurology 1996;47(5):1284-90.
1996: Dittrich F; Ochs G; Grosse-Wilde A; Berweiler U; Yan Q; Miller J A; Toyka K V; Sendtner M
Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons.
Experimental neurology 1996;141(2):225-39.
1996: Toyka K V
The immune system in neurologic disease: selected recent developments.
Acta neurologica Belgica 1996;96(3):185-8.
1996: Gold R; Pepinsky R B; Zettl U K; Toyka K V; Hartung H P
Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat.
Journal of neuroimmunology 1996;69(1-2):157-64.
1996: Bourde O; Kiefer R; Toyka K V; Hartung H P
Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction.
Journal of neuroimmunology 1996;69(1-2):135-40.
1996: Morrissey S P; Deichmann R; Syha J; Simonis C; Zettl U; Archelos J J; Jung S; Stodal H; Lassmann H; Toyka K V; Haase A; Hartung H P
Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies.
Journal of neuroimmunology 1996;69(1-2):85-93.
1996: Nelles E; Bützler C; Jung D; Temme A; Gabriel H D; Dahl U; Traub O; Stümpel F; Jungermann K; Zielasek J; Toyka K V; Dermietzel R; Willecke K
Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(18):9565-70.
1996: Gold R; Zielasek J; Schröder J M; Sellhaus B; Cedarbaum J; Hartung H P; Sendtner M; Toyka K V
Treatment with ciliary neurotrophic factor does not improve regeneration in experimental autoimmune neuritis of the Lewis rat.
Muscle & nerve 1996;19(9):1177-80.
1996: Magyar J P; Martini R; Ruelicke T; Aguzzi A; Adlkofer K; Dembic Z; Zielasek J; Toyka K V; Suter U
Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(17):5351-60.
1996: Jung S; Toyka K; Hartung H P
T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
Brain : a journal of neurology 1996;119 ( Pt 4)():1079-90.
1996: Jung S; Zielasek J; Köllner G; Donhauser T; Toyka K; Hartung H P
Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
Journal of neuroimmunology 1996;68(1-2):1-11.
1996: Zielasek J; Martini R; Toyka K V
Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations.
Muscle & nerve 1996;19(8):946-52.
1996: Toyka K V; Hartung H P
Chronic inflammatory polyneuritis and neuropathies.
Current opinion in neurology 1996;9(3):240-50.
1996: Marx A; Wilisch A; Schultz A; Greiner A; Magi B; Pallini V; Schalke B; Toyka K; Nix W; Kirchner T; Müller-Hermelink H K
Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.
The American journal of pathology 1996;148(6):1839-50.
1996: Hartung H P; Zielasek J; Jung S; Toyka K V
Effector mechanisms in demyelinating neuropathies.
Revue neurologique 1996;152(5):320-7.
1996: Gold R; Schmied M; Tontsch U; Hartung H P; Wekerle H; Toyka K V; Lassmann H
Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo.
Brain : a journal of neurology 1996;119 ( Pt 2)():651-9.
1996: Winterholler M; Claus D; Bockelbrink A; Borasio G D; Pongratz D E; Schrank B; Toyka K; Neundörfer B
[Home ventilation in neuromuscular diseases in adults. Presentation of recommendations of the Bavarian Muscle Centers of the DGM]
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 2():45-7.
1996: Schmidt B; Toyka K V; Kiefer R; Full J; Hartung H P; Pollard J
Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
Muscle & nerve 1996;19(4):474-87.
1996: Naumann M; Reichmann H; Goebel H H; Moll C; Toyka K V
Glucocorticoid-sensitive hereditary inclusion body myositis.
Journal of neurology 1996;243(2):126-30.
1996: Morrissey S P; Stodal H; Zettl U; Simonis C; Jung S; Kiefer R; Lassmann H; Hartung H P; Haase A; Toyka K V
In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema.
Brain : a journal of neurology 1996;119 ( Pt 1)():239-48.
1996: Gold R; Zielasek J; Kiefer R; Toyka K V; Hartung H P
Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro.
Cellular immunology 1996;168(1):69-77.
1996: Stangel M; Zettl U K; Mix E; Zielasek J; Toyka K V; Hartung H P; Gold R
H2O2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts.
Journal of neuropathology and experimental neurology 1996;55(1):36-43.
1996: Kiefer R; Funa K; Schweitzer T; Jung S; Bourde O; Toyka K V; Hartung H P
Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course.
The American journal of pathology 1996;148(1):211-23.
1996: Hartung H P; Willison H; Jung S; Pette M; Toyka K V; Giegerich G
Autoimmune responses in peripheral nerve.
Springer seminars in immunopathology 1996;18(1):97-123.
1996: Zetti U K; Gold R; Toyka K V; Hartung H P
In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat.
Acta neuropathologica 1996;91(4):360-7.
1995: Buchwald B; Weishaupt A; Toyka K V; Dudel J
Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.
Neuroscience letters 1995;201(2):163-6.
1995: Weishaupt A; Giegerich G; Jung S; Gold R; Enders U; Pette M; Hayasaka K; Hartung H P; Toyka K V
T cell antigenic and neuritogenic activity of recombinant human peripheral myelin P2 protein.
Journal of neuroimmunology 1995;63(2):149-56.
1995: Jung S; Toyka K V; Hartung H P
Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats.
Neuroscience letters 1995;200(3):167-70.
1995: Flachenecker P; Toyka K V; Hartung H P
[Active vaccinations in multiple sclerosis]
Deutsche medizinische Wochenschrift (1946) 1995;120(44):1513-6.
1995: Martini R; Zielasek J; Toyka K V; Giese K P; Schachner M
Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies.
Nature genetics 1995;11(3):281-6.
1995: Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka K V; Suter U
Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
Nature genetics 1995;11(3):274-80.
1995: Gold R; Toyka K V; Hartung H P
Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells.
Cellular immunology 1995;165(1):65-70.
1995: Weilbach F X; Toyka K V; Hartung H P
[Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis]
Der Nervenarzt 1995;66(8):643-7.
1995: Hartung H P; Reiners K; Archelos J J; Michels M; Seeldrayers P; Heidenreich F; Pflughaupt K W; Toyka K V
Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging.
Annals of neurology 1995;38(2):186-93.
1995: Naumann M; Schalke B; Klopstock T; Reichmann H; Lange K W; Wiesbeck G; Toyka K V; Reiners K
Neurological multisystem manifestation in multiple symmetric lipomatosis: a clinical and electrophysiological study.
Muscle & nerve 1995;18(7):693-8.
1995: Zettl U K; Gold R; Toyka K V; Hartung H P
Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat.
Journal of neuropathology and experimental neurology 1995;54(4):540-7.
1995: Reichmann H; Schalke B; Seibel P; Naumann M; Toyka K
Sarcoid myopathy and mitochondrial respiratory chain defects: clinicopathological, biochemical and molecular biological analyses.
Neuromuscular disorders : NMD 1995;5(4):277-83.
1995: Hartung H P; Archelos J J; Zielasek J; Gold R; Koltzenburg M; Reiners K H; Toyka K V
Circulating adhesion molecules and inflammatory mediators in demyelination: a review.
Neurology 1995;45(6 Suppl 6):S22-32.
1995: Gold R; Giegerich G; Hartung H P; Toyka K V
T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(13):5850-4.
1995: Pette M; Gold R; Pette D F; Hartung H P; Toyka K V
Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes. A possible mechanism of its immunosuppressive action.
Immunopharmacology 1995;30(1):59-69.
1995: Jung S; Toyka K; Hartung H P
Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
European journal of immunology 1995;25(5):1391-8.
1995: Harvey G K; Toyka K V; Zielasek J; Kiefer R; Simonis C; Hartung H P
Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
Muscle & nerve 1995;18(4):388-94.
1995: Zielasek J; Jung S; Gold R; Liew F Y; Toyka K V; Hartung H P
Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 1995;58(1):81-8.
1995: Hartung H P; Pollard J D; Harvey G K; Toyka K V
Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.
Muscle & nerve 1995;18(2):154-64.
1995: Hartung H P; Pollard J D; Harvey G K; Toyka K V
Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.
Muscle & nerve 1995;18(2):137-53.
1995: Gold R; Hartung H P; Toyka K V
[Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action]
Fortschritte der Neurologie-Psychiatrie 1995;63(1):17-29.
1995: Zielasek J; Reichmann H; Künzig H; Jung S; Hartung H P; Toyka K V
Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat.
Neuroscience letters 1995;184(2):129-32.
1995: Giegerich G; Stangel M; Torres-Nagel N; Hünig T; Toyka K V
Sequence and diversity of rat T-cell receptor Tcra V8 gene segments.
Immunogenetics 1995;42(4):304-5.
1994: Pette M; Hartung H P; Toyka K V
[Immune augmenting therapy as treatment of multiple sclerosis. Warning regarding a potentially toxic alternative treatment method]
Der Nervenarzt 1994;65(12):878-90.
1994: Hartung H P; Gold R; Zielasek J; Archelos J J; Toyka K V
[Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)]
Der Nervenarzt 1994;65(12):807-18.
1994: Jung S; Schluesener H J; Schmidt B; Fontana A; Toyka K V; Hartung H P
Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
Immunology 1994;83(4):545-51.
1994: Jung S; Toyka K V; Hartung H P
Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
Clinical and experimental immunology 1994;98(3):494-502.
1994: Pette M; Linington C; Gengaroli C; Grosse-Wilde H; Toyka K V; Hartung H P
T lymphocyte recognition sites on peripheral nerve myelin P0 protein.
Journal of neuroimmunology 1994;54(1-2):29-34.
1994: Gold R; Schmied M; Giegerich G; Breitschopf H; Hartung H P; Toyka K V; Lassmann H
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques.
Laboratory investigation; a journal of technical methods and pathology 1994;71(2):219-25.
1994: Stangel M; Toyka K V; Hartung H P; Giegerich G
Bacterial expression of a soluble T-cell receptor alpha chain.
Biochemical and biophysical research communications 1994;202(3):1280-4.
1994: Harvey G K; Toyka K V; Hartung H P
Effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo.
Journal of the neurological sciences 1994;125(1):102-9.
1994: Zettl U K; Gold R; Hartung H P; Toyka K V
Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat.
Neuroscience letters 1994;176(1):75-9.
1994: Zielasek J; Ritter G; Magi S; Hartung H P; Toyka K V
A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.
Journal of neurology 1994;241(8):475-80.
1994: Hartung H P; Reiners K; Michels M; Hughes R A; Heidenreich F; Zielasek J; Enders U; Toyka K V
Serum levels of soluble E-selectin (ELAM-1) in immune-mediated neuropathies.
Neurology 1994;44(6):1153-8.
1994: Pette M; Gengaroli C; Hartung H P; Greiner A; Giegerich G; Toyka K V
Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: implications for immunological studies on inflammatory demyelinating neuropathies.
Journal of neuroimmunology 1994;52(1):47-52.
1994: Archelos J J; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka K V; Hartung H P
Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Laboratory investigation; a journal of technical methods and pathology 1994;70(5):667-75.
1994: Klopstock T; Naumann M; Schalke B; Bischof F; Seibel P; Kottlors M; Eckert P; Reiners K; Toyka K V; Reichmann H
Multiple symmetric lipomatosis: abnormalities in complex IV and multiple deletions in mitochondrial DNA.
Neurology 1994;44(5):862-6.
1994: Pette M; Hartung H P; Toyka K V
[Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]
Der Nervenarzt 1994;65(4):271-4.
1994: Kiefer R; Supler M L; Toyka K V; Streit W J
In situ detection of transforming growth factor-beta mRNA in experimental rat glioma and reactive glial cells.
Neuroscience letters 1994;166(2):161-4.
1993: Naumann M; Toyka K V; Goebel H H; Hofmann E; Reichmann H
Focal myositis of the temporal muscle.
Muscle & nerve 1993;16(12):1374-6.
1993: Jung S; Huitinga I; Schmidt B; Zielasek J; Dijkstra C D; Toyka K V; Hartung H P
Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis.
Journal of the neurological sciences 1993;119(2):195-202.
1993: Hartung H P; Michels M; Reiners K; Seeldrayers P; Archelos J J; Toyka K V
Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis.
Neurology 1993;43(11):2331-5.
1993: Pette M; Liebert U G; Göbel U; Grosse-Wilde H; Hartung H P; Toyka K V
Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals.
Neurology 1993;43(10):2019-25.
1993: Archelos J J; Mäurer M; Jung S; Toyka K V; Hartung H P
Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1.
Brain : a journal of neurology 1993;116 ( Pt 5)():1043-58.
1993: Enders U; Karch H; Toyka K V; Michels M; Zielasek J; Pette M; Heesemann J; Hartung H P
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Annals of neurology 1993;34(2):136-44.
1993: Archelos J J; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka K V; Hartung H P
Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Annals of neurology 1993;34(2):145-54.
1993: Archelos J J; Roggenbuck K; Schneider-Schaulies J; Toyka K V; Hartung H P
Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.
Journal of the neurological sciences 1993;117(1-2):197-205.
1993: Jung S; Schluesener H J; Toyka K V; Hartung H P
Modulation of EAE by vaccination with T cell receptor peptides: V beta 8 T cell receptor peptide-specific CD4+ lymphocytes lack direct immunoregulatory activity.
Journal of neuroimmunology 1993;45(1-2):15-22.
1993: Archelos J J; Roggenbuck K; Schneider-Schaulies J; Linington C; Toyka K V; Hartung H P
Production and characterization of monoclonal antibodies to the extracellular domain of P0.
Journal of neuroscience research 1993;35(1):46-53.
1993: Zielasek J; Archelos J J; Toyka K V; Hartung H P
Expression of intercellular adhesion molecule-1 on rat microglial cells.
Neuroscience letters 1993;153(2):136-9.
1993: Zielasek J; Jung S; Schmidt B; Ritter G; Hartung H P; Toyka K
Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines.
Journal of neuroimmunology 1993;43(1-2):103-11.
1992: Hartung H P; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos J J; Toyka K V
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
Journal of neuroimmunology 1992;40(2-3):197-210.
1992: Pohl-Koppe A; Dahm C; Kühn J E; Hamann J; Fuhrmeister U; Gabriel M; Grüninger W; Metze H; Ranke M; Toyka K
[New aspects in the diagnosis of herpes simplex virus encephalitis--case reports and virologic findings]
Der Nervenarzt 1992;63(8):495-50.
1992: Jung S; Krämer S; Schluesener H J; Hünig T; Toyka K; Hartung H P
Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(12):3768-75.
1992: Zielasek J; Tausch M; Toyka K V; Hartung H P
Production of nitrite by neonatal rat microglial cells/brain macrophages.
Cellular immunology 1992;141(1):111-20.
1992: Geuder K I; Marx A; Witzemann V; Schalke B; Toyka K; Kirchner T; Müller-Hermelink H K
Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis.
Developmental immunology 1992;2(2):69-75.
1991: Jung S; Schluesener H J; Toyka K; Hartung H P
T cell vaccination does not induce resistance to experimental autoimmune neuritis.
Journal of neuroimmunology 1991;35(1-3):1-11.
1991: Hartung H P; Reiners K; Schmidt B; Stoll G; Toyka K V
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Annals of neurology 1991;30(1):48-53.
1990: Hartung H P; Toyka K V
T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome.
Annals of neurology 1990;27 Suppl():S57-63.

Sign-in to see more